About PeerVoice Immunology & Infectious Disease Audio
PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Immunology & Infectious Disease that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: https://peervoice.com.
David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real World
For the complete activity, including supporting material, please visit https://www.peervoice.com/DMZ860. Presented by David Alain Wohl, MD; and Antonella Castagna, MD. Learning Objectives: Explain the clinical rationale for rapid antiretroviral therapy (ART) in people with HIV; Evaluate evidence on the benefits and limitations of rapid ART in HIV; Formulate practical steps to align rapid ART practices in HIV with both guideline expectations and real-world realities.
4 Feb 2026
Yohei Doi, MD, PhD - Know the Risk, Act on Evidence: Strategic Interventions in COVID-19 Care of High-Risk Patients
For the complete activity, including supporting material, please visit https://www.peervoice.com/SDW860. Presented by Yohei Doi, MD, PhD and Sarah Jarvis, MBE, FRCGP. Learning Objectives: Differentiate key clinical and demographic factors, including age, comorbidities, and immune status, that define high-risk COVID-19 patient profiles; Propose strategies to improve early identification of high-risk patients for appropriate COVID-19 treatment; Interpret regional epidemiological data from Europe and Asia-Pacific to contextualise risk profiles for diverse patient populations; Apply clinical criteria and actionable cues to recognise the optimal therapeutic window for initiating COVID-19 treatment in practice; Evaluate the role of overlapping risk factors in intensifying COVID-19 disease progression; Assess the data from real-world studies of the potential impact of established treatments on clinical outcomes, including long COVID.
4 Feb 2026
Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established Therapies
For the complete activity, including supporting material, please visit https://www.peervoice.com/XZR860. Presented by Melanie J. Davies, CBE, MBChB, MD, FMedSci and Linong Ji, MD. Learning Objectives: Describe the importance of optimal cost-effective approaches to the pharmacologic management of type 2 diabetes mellitus (T2DM); Evaluate the role of established medications for T2DM for avoiding potential cardiorenal complications in patients with T2DM; Propose practical approaches to address cost and clinical effectiveness for patients with T2DM.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
1 ratings
Podcast Authority Score: 33 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
